Page 2

  • psilocybin lab
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    A big moment is coming for psychedelics

    Compass Pathways expects to publish the first phase 3 results from a large-scale, psilocybin drug trial by the end of this quarter.

  • A sign spelling Novartis hangs on the side of a building.
    Image attribution tooltip
    Sedat Suna via Getty Images
    Image attribution tooltip

    Novartis scores NFL deal to tackle health outcomes

    The non-traditional marketing approach comes amid a potential crackdown on TV drug ads.